New hope for Tough-to-Treat blood cancers
NCT ID NCT07339527
Summary
This study is testing a new drug combination for adults whose T-cell or NK-cell lymphoma has returned or hasn't responded to standard treatments. The main goals are to find a safe and effective dose and to see if the treatment can shrink or eliminate the cancer. It will involve about 60 participants across multiple hospitals.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MATURE T-CELL AND NK-CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.